Analyst Price Targets — DCGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 12, 2025 11:42 am | Richard Close | Canaccord Genuity | $1.50 | $1.10 | StreetInsider | DocGo (DCGO) PT Lowered to $1.50 at Canaccord Genuity |
| February 28, 2025 1:47 pm | — | Deutsche Bank | $2.85 | $3.09 | TheFly | DocGo downgraded to Hold from Buy at Deutsche Bank |
| May 9, 2024 6:44 am | Richard Close | Canaccord Genuity | $5.00 | $3.50 | StreetInsider | DocGo (DCGO) PT Lowered to $5 at Canaccord Genuity |
| April 10, 2024 6:58 am | David Grossman | Stifel Nicolaus | $8.00 | $3.17 | StreetInsider | DocGo (DCGO) PT Lowered to $8 at Stifel |
| April 10, 2024 4:58 am | David Larsen | BTIG | $11.00 | $3.85 | StreetInsider | DocGo (DCGO) PT Lowered to $11 at BTIG |
| April 19, 2022 8:52 am | — | Deutsche Bank | $11.00 | $8.11 | Benzinga | Deutsche Bank Initiates Coverage On DocGo with Buy Rating, Announces Price Target of $11 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for DCGO

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

DocGo Inc. (DCGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

DocGo Inc. (Nasdaq: DCGO) (âDocGoâ or the âCompanyâ), a leading provider of technology-enabled mobile health and medical transportation services, today

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its PTI Health by DocGo subsidiary has launched mobile phlebotomy services in Southern Florida. In conjunction with this launch, PTI Health has expanded its relationship with a major national clinical laboratory to cover…

DocGo NASDAQ: DCGO Chief Executive Officer Lee Bienstock outlined the company's transition away from COVID-related, migrant and emergency-response programs and toward its “evergreen” medical transportation and mobile health businesses during a presentation at the 21st Annual Needham Technology, Media, and Consumer Conference.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DCGO.
U.S. House Trading
No House trades found for DCGO.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
